Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,440.70
-43.90 (-2.96%)
Jan 28, 2026, 1:40 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 281.44 billion as of January 27, 2026. Its market cap has increased by 4.58% in one year.
Market Cap
281.44B
Enterprise Value
294.33B
Revenue
84.49B
Ranking
n/a
PE Ratio
35.46
Stock Price
1,440.70
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 281.44B, an increase of 9.53%. That is a compound annual growth rate of 6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 281.44B | 8.80% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |
| Ajanta Pharma | 337.15B |
| Gland Pharma | 276.12B |
| Wockhardt | 219.62B |
| Piramal Pharma | 201.05B |
| Eris Lifesciences | 191.94B |